Companies similar to MACROGENICS INC (MGNX)
Health Care · NASDAQ
MACROGENICS INC (MGNX)'s closest peers include Regeneron Pharmaceuticals (REGN), Moderna (MRNA), SYNDAX PHARMACEUTICALS INC (SNDX), Incyte (INCY), Bristol Myers Squibb (BMY) and Merck & Co. (MRK). This peer set is drawn from MGNX's enriched company profile and is informational only — not financial advice.
Similar companies
-
Regeneron PharmaceuticalsREGNHealth Care
Regeneron develops and commercializes monoclonal antibody and other biologics therapies across immunology, oncology, infectious disease, and other therapeutic…
$678.94 (as of 2026-07-16) · market cap $70.5B
-
ModernaMRNAHealth Care
Moderna is an unprofitable mRNA vaccine and therapeutic company pivoting from peak COVID revenues with a diversified pipeline facing intense competition and…
$63.15 (as of 2026-07-16) · market cap $25.1B
-
SYNDAX PHARMACEUTICALS INCSNDXHealth Care
Syndax is a commercial-stage biopharmaceutical company with two FDA-approved oncology drugs (REVUFORJ and NIKTIMVO) partnered with major pharma, generating…
$22.71 (as of 2026-07-16) · market cap $2.0B
-
IncyteINCYHealth Care
A biopharmaceutical company pioneering targeted therapies for blood cancers and inflammatory diseases, with flagship JAK inhibitor JAKAFI generating…
$116.65 (as of 2026-07-16) · market cap $23.2B
-
Bristol Myers SquibbBMYHealth Care
A diversified biopharmaceutical company leveraging immunotherapy, cell therapies, and small-molecule platforms to address cancer, autoimmune disease, and…
$60.51 (as of 2026-07-16) · market cap $121.8B
-
Merck & Co.MRKHealth Care
Global pharmaceutical and vaccine leader with oncology, infectious disease, and animal health franchises, anchored by blockbuster immunotherapy Keytruda.
$127.63 (as of 2026-07-16) · market cap $311.9B
Not quite? Describe exactly what you want →
Peers are drawn from MGNX's enriched profile (the same similarity signal the chat uses for "companies like MGNX"). See the full profile: MACROGENICS INC (MGNX).
Last updated 2026-07-16.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.